Breaking News Instant updates and real-time market news.

ADAP

Adaptimmune

$6.01

-0.55 (-8.38%)

05:49
10/13/16
10/13
05:49
10/13/16
05:49

Adaptimmune selloff yesterday unwarranted, says Citi

Citi analyst Robyn Karnauskas says yesterday's ovarian cancer non-response data from Adaptimmune Therapeutics are not new. Investors are concerned as the press release noted that no objective clinical responses were seen among initial ovarian cancer patients treated with ADAP TCR treatment, but information was disclosed at ASCO in June, Karnauskas writes in a research note. The analyst keeps a Buy rating on Adaptimmune with a $15 price target.

ADAP Adaptimmune
$6.01

-0.55 (-8.38%)

02/25/16
02/25/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Boston Scientific (BSX) initiated with a Buy at SunTrust by analyst Bruce Nudell, who expects an organic growth accelerating through 2018 driven by structural heart sales and core market stabilization. 2. Kite Pharma (KITE) initiated with a Buy, with analyst Robyn Karnauskas saying that Kite's technology could be the first to market and its data in the largest blood cancer market look similar to competition. The analyst also started Juno Therapeutics (JUNO) and Adaptimmune (ADAP) with Buy ratings. 3. Insulet (PODD) initiated with a Sell at Empire by analyst Cathy Reese, who said the company has several issues with its OmniPod System that will not be remedied with planned upgrades. 4. Biogen (BIIB) initiated with a Buy at Citi. 5. Crown Castle (CCI) initiated with a Buy at SunTrust. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/04/16
LEER
08/04/16
NO CHANGE
LEER
Outperform
Adaptimmune partial clinical hold on planned trial 'surprising,' says Leerink
Leerink analyst Michael Schmidt sees the announced partial clinical hold on Adaptimmune's liposarcoma study as "surprising" and notes that it introduces some additional risk. However, the analyst says the news does not "fundamentally" change his investment thesis on Adaptimmune as he expects a rapid resolution. Schmidt reiterates an Outperform rating on the shares.
08/26/16
SBSH
08/26/16
NO CHANGE
SBSH
Buy
Adaptimmune partial clinical hold may be lifted within weeks, says Citi
Citi analyst Robyn Karnauskas said that after traveling with several members of Adaptimmune's management team, including its CEO and CFO, she came away feeling that their TCR platform remains in the lead despite delays. The FDA's partial clinical hold in myxoid round cell liposarcoma, or MRCLS, was not related to safety or efficacy of the product and Karnauskas sees the potential for the FDA to possibly reverse the partial clinical hold within a few weeks, she tells investors. Citi keeps a Buy rating on Adaptimmune shares.
09/30/16
RAJA
09/30/16
INITIATION
Target $16
RAJA
Outperform
Adaptimmune initiated with an Outperform at Raymond James
Raymond James analyst Reni Benjamin initiated Adaptimmune with a Buy and a $16 price target saying it is a leading player in the engineered T cell receptor therapy space, with a growing product portfolio concentrating primarily in the solid tumor market.

TODAY'S FREE FLY STORIES

GSK

GlaxoSmithKline

$37.74

0.24 (0.64%)

11:54
01/16/18
01/16
11:54
01/16/18
11:54
Upgrade
GlaxoSmithKline rating change  »

GlaxoSmithKline upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

  • 25

    Mar

GSK

GlaxoSmithKline

$37.76

0.2646 (0.71%)

11:51
01/16/18
01/16
11:51
01/16/18
11:51
Upgrade
GlaxoSmithKline rating change  »

GlaxoSmithKline upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

  • 25

    Mar

SPY

SPDR S&P 500 ETF Trust

$278.99

1.07 (0.39%)

, SPX

S&P 500

11:50
01/16/18
01/16
11:50
01/16/18
11:50
Periodicals
Steve Bannon subpoenaed before grand jury by Mueller, NY Time says »

Special counsel Robert…

SPY

SPDR S&P 500 ETF Trust

$278.99

1.07 (0.39%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBR

Petrobras

$11.67

0.1978 (1.72%)

11:50
01/16/18
01/16
11:50
01/16/18
11:50
Options
Large spreads in Petrobras as shares reach 52-week highs »

Large spreads in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$62.38

3.72 (6.34%)

11:45
01/16/18
01/16
11:45
01/16/18
11:45
Options
Merck call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 25

    Jan

  • 02

    Feb

  • 08

    Feb

  • 25

    Mar

  • 03

    Apr

  • 23

    Oct

11:45
01/16/18
01/16
11:45
01/16/18
11:45
General news
Treasury's $90 B bill auction were mixed, with the 3-month outperforming »

Treasury's $90 B…

TTMI

TTM Technologies

$17.39

0.59 (3.51%)

11:45
01/16/18
01/16
11:45
01/16/18
11:45
Conference/Events
TTM Technologies management to meet with SunTrust »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 17

    Jan

11:40
01/16/18
01/16
11:40
01/16/18
11:40
General news
U.S. VIX equity volatility is up nearly 10% »

U.S. VIX equity…

LPI

Laredo Petroleum

$11.09

0.015 (0.14%)

11:36
01/16/18
01/16
11:36
01/16/18
11:36
Initiation
Laredo Petroleum initiated  »

Laredo Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:35
01/16/18
01/16
11:35
01/16/18
11:35
General news
6-Month Bill Auction Total Amount data reported »

6-Month Bill Auction…

11:34
01/16/18
01/16
11:34
01/16/18
11:34
General news
3-Month Bill Auction Total Amount data reported »

3-Month Bill Auction…

EVRI

Everi Holdings

$7.85

-0.09 (-1.13%)

, SGMS

Scientific Games

11:31
01/16/18
01/16
11:31
01/16/18
11:31
Hot Stocks
Everi Holdings names Harper Ko EVP, Chief Legal Officer - General Counsel »

Everi Holdings (EVRI)…

EVRI

Everi Holdings

$7.85

-0.09 (-1.13%)

SGMS

Scientific Games

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GME

GameStop

$17.79

0.03 (0.17%)

11:30
01/16/18
01/16
11:30
01/16/18
11:30
Options
Put buyers in Gamestop as shares attempt to stabilize »

Put buyers in Gamestop as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOG

Extraction Oil & Gas

$14.16

-0.13 (-0.91%)

11:28
01/16/18
01/16
11:28
01/16/18
11:28
Conference/Events
Extraction Oil & Gas management to meet with SunTrust »

Field trip to company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 24

    Jan

  • 28

    Feb

  • 15

    May

11:27
01/16/18
01/16
11:27
01/16/18
11:27
Conference/Events
Cowen healthcare policy analyst holds an analyst/industry conference call »

Healthcare Policy Analyst…

11:25
01/16/18
01/16
11:25
01/16/18
11:25
Conference/Events
Wolfe Research airlines analyst hosts a luncheon »

Airlines Analyst Keay…

C

Citi

$77.46

0.615 (0.80%)

11:22
01/16/18
01/16
11:22
01/16/18
11:22
Hot Stocks
Breaking Hot Stocks news story on Citi »

Citi CEO Corbat says open…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 24

    Jan

TTMI

TTM Technologies

$17.39

0.59 (3.51%)

11:21
01/16/18
01/16
11:21
01/16/18
11:21
Conference/Events
TTM Technologies management to meet with SunTrust »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 17

    Jan

PAAS

Pan American Silver

$16.66

0.48 (2.97%)

11:20
01/16/18
01/16
11:20
01/16/18
11:20
Options
Pan Am Silver call options quickly double in value »

Pan Am Silver call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

C

Citi

$77.47

0.625 (0.81%)

11:19
01/16/18
01/16
11:19
01/16/18
11:19
Hot Stocks
Breaking Hot Stocks news story on Citi »

Citi CEO says 'not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 24

    Jan

$NSD

NASDAQ Market Internals

11:17
01/16/18
01/16
11:17
01/16/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

11:16
01/16/18
01/16
11:16
01/16/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
01/16/18
01/16
11:15
01/16/18
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

11:15
01/16/18
01/16
11:15
01/16/18
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

11:15
01/16/18
01/16
11:15
01/16/18
11:15
General news
Breaking General news story  »

4-Week Bill Auction to be…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.